Schedule 13G ownership disclosure

C4 Therapeutics Inc

COM STK · CUSIP: 12529R107

Event date: 2025-09-30

Filing-level shares
4,852,741.00
Percent of class
6.8%
  • Wasatch Advisors LP

    Shares: 4,852,741.00 · Class: 6.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000814133-25-000117
Form type
SCHEDULE 13G/A
Filer
C4 Therapeutics, Inc.
CIK
CIK 1662579
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub